Desq Long
Sign in
SEC FORM 4
$0.00

FENNEC PHARMACEUTICALS INC. (FENC)

Acquisition (code A) of 1,159 shares at $0 per share.

Reporting Person Hackman Jeffrey S. · Officer Title Chief Executive Officer · Transaction Code A

Traded Aug 31, 2026 · Disclosed Aug 31, 2026

Source: SEC Form 4 · 0001926254-26-000014 · filed 2026-08-31 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "FENNEC PHARMACEUTICALS INC. (FENC)." Disclosed 2026-08-31. https://desqlong.com/cards/0001926254-26-000014-1 (retrieved 2026-09-26).